default author photo

Tom G. Caniels

University of Amsterdam - Department of Medical Microbiology and Infection Prevention

University of Amsterdam - Department of Medical Microbiology

Amsterdam , 1105

Netherlands

SCHOLARLY PAPERS

3

DOWNLOADS

130

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Two-Component Spike Nanoparticle Vaccine Protects Macaques from SARS-CoV-2 Infection

Number of pages: 42 Posted: 24 Nov 2020
University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Life and Soft, Institut Cochin, University of Southampton - School of Biological Sciences, University of Southampton - School of Biological Sciences, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Amsterdam Institute for Infection and Immunity, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, Erasmus Medical Center - Viroscience Department, Erasmus Medical Center - Department of Viroscience, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, University of Washington - Department of Biochemistry, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Medical Microbiology, Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), AIMM Therapeutics BV, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, Erasmus Medical Center - Viroscience Department, University of Amsterdam - Amsterdam Public Health Research Institute, Life and Soft, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, University of Southampton - School of Biological Sciences, University of Washington - Department of Biochemistry, University of Paris-Saclay - Molecular Genetics of RNA Viruses, University of Amsterdam - Department of Medical Microbiology, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT) and University of Amsterdam - Department of Medical Microbiology
Downloads 52 (1,052,702)

Abstract:

Loading...

SARS-CoV-2 vaccine, Self-assembling protein nanoparticle vaccine, SARS-CoV-2 NHP challenge study

2.

HIV-1 Germline-Targeting Vaccine Regimen Selects for Rare Immunoglobulin Insertions and Deletions Typical of VRC01-Class Antibodies

Number of pages: 49 Posted: 21 Sep 2022
University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Medical Microbiology, Applied Biomedical Science Institute, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, Applied Biomedical Science Institute, University of Amsterdam - Department of Medical Microbiology, University of Southampton - School of Biological Sciences, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, Cornell University - Department of Microbiology and Immunology, Applied Biomedical Science Institute, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, Duke University - Duke Human Vaccine Institute, Duke University - Department of Surgery, Duke University - Department of Surgery, Duke University - Duke Human Vaccine Institute, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Amsterdam Institute for Infection and Immunity, University of Amsterdam - Department of Medical Microbiology, Duke University - Department of Surgery, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, University of Southampton - School of Biological Sciences, Cornell University - Department of Microbiology and Immunology, Cornell University - Department of Microbiology and Immunology, Duke University - Duke Human Vaccine Institute, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, Duke University - Duke Human Vaccine Institute, Applied Biomedical Science Institute and University of Amsterdam - Department of Medical Microbiology
Downloads 48 (1,109,210)

Abstract:

Loading...

HIV-1 Env, vaccines, germline-targeting, insertions, deletions, neutralizing antibodies, bNAbs, mouse model, NGS

3.

Identification of New Drugs to Counteract Anti-Spike IgG-Induced Hyperinflammation in Severe COVID-19

Number of pages: 30 Posted: 20 Jan 2023
University of Amsterdam - Center for Experimental and Molecular Medicine, University of Amsterdam - Center for Experimental and Molecular Medicine, University of Reading - School of Biological Sciences, University of Amsterdam - Department of Pulmonary Medicine, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Amsterdam Cardiovascular Sciences, University of Amsterdam - Center for Experimental and Molecular Medicine, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Center for Experimental and Molecular Medicine, University of Amsterdam - Department of Intensive Care, Independent, Sanquin Research - Department of Immunopathology, University of Amsterdam - Department of Pulmonary Medicine, University of Amsterdam - Department of Pulmonary Medicine, University of Reading - School of Biological Sciences, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Amsterdam Cardiovascular Sciences and University of Amsterdam - Center for Experimental and Molecular Medicine
Downloads 30 (1,332,057)

Abstract:

Loading...

COVID-19 treatment, SYK, macrophage, FcR, entospletinib, Inflammation, IL-6, thrombosis, endothelial dysfunction, platelet